Li, Yanli
Liu, Lizhu
You, Ruiming
Li, Qingwan
Jiang, Zhaojuan
Pu, Hongjiang
Li, Zhenhui
Chen, Xiaobo
Funding for this research was provided by:
the National Natural Scientific Foundation of China (82001986)
the Outstanding Youth Science Foundation of Yunnan Basic Research Project (202101AW070001)
the Yunnan Basic Research Project (202201AT070010)
Innovation Team of Kunming Medical University (CXTD202110)
Article History
Received: 23 August 2023
Accepted: 13 November 2023
First Online: 21 November 2023
Declarations
:
: This study was approved by the Ethics Committee of the Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital & Yunnan Cancer Center) before the commencement of the research. All participants had implemented informed consent and signed the informed consent before the investigation. We confirm that all methods (diagnosis, staging, and treatment of lung cancer) were carried out by the “lung cancer clinical practice guidelines” from the National Comprehensive Cancer Network (NCCN) of the USA. The methods in this study were followed by the relevant guidelines.
: Not applicable.
: The authors declare that they have no competing interests.